Home Cart Sign in  
Chemical Structure| 201410-53-9 Chemical Structure| 201410-53-9

Structure of Talarozole
CAS No.: 201410-53-9

Chemical Structure| 201410-53-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Talarozole is a potent and selective inhibitor of cytochrome P450 26-mediated breakdown of endogenous all-trans retinoic acid for the treatment of psoriasis and acne.

Synonyms: R115866

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Talarozole

CAS No. :201410-53-9
Formula : C21H23N5S
M.W : 377.51
SMILES Code : CCC(CC)C(C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1)N4N=CN=C4
Synonyms :
R115866
MDL No. :MFCD17166995

Safety of Talarozole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00725348 Psoriasis Phase 2 Completed - Netherlands ... More >> Academisch Ziekenhuis Maastricht Maastricht, Netherlands Universitair Medisch Centrum Nijmegen Sint Radboud Nijmegen, Netherlands Less <<
NCT00719121 Cutaneous Inflammation Phase 1 Completed - Belgium ... More >> Department of DermatopathologyCentre Hospitalier Universitaire du Sart Tilman Liege, Belgium, B-4000 Less <<
NCT00716144 Psoriasis Phase 2 Completed - Germany ... More >> GSK Investigational Site Augsburg, Germany GSK Investigational Site Berlin, Germany GSK Investigational Site Dresden, Germany GSK Investigational Site Frankfurt, Germany GSK Investigational Site Hamburg, Germany GSK Investigational Site Salzwedel, Germany Ireland GSK Investigational Site Cork, Ireland Netherlands GSK Investigational Site Maastricht, Netherlands GSK Investigational Site Nijmegen, Netherlands Russian Federation GSK Investigational Site Korolev, Russian Federation GSK Investigational Site Lipetsk, Russian Federation GSK Investigational Site Moscow, Russian Federation GSK Investigational Site Novgorod, Russian Federation GSK Investigational Site Smolensk, Russian Federation GSK Investigational Site St. Petersburg, Russian Federation GSK Investigational Site Yaroslavl, Russian Federation United Kingdom GSK Investigational Site Aberdeen, United Kingdom GSK Investigational Site Amersham, United Kingdom GSK Investigational Site Coventry, United Kingdom GSK Investigational Site Glasgow, United Kingdom GSK Investigational Site Manchester, United Kingdom GSK Investigational Site Norwich, United Kingdom Less <<
NCT00716144 - Completed - -
NCT00725439 Acne Phase 2 Completed - Belgium ... More >> Department of Dermatology, UZ Brussel Brussel, Belgium, B-1090 Private Practice in Dermatology Vilvoorde, Belgium, B-1800 Netherlands Albert Schweitzer Hospital, Dermatology Zwijndrecht, Netherlands, NL-3331 LZ Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.26mL

13.24mL

2.65mL

1.32mL

26.49mL

5.30mL

2.65mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories